http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010524938-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D489-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D489-08
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D489-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J23-44
filingDate 2008-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2010-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2010524938-A
titleOfInvention Novel opiate reduction using catalytic hydrogen transfer reaction
abstract An improved opiate synthesis scheme is provided. Improvements to the oxidation of oripavine and oripavine derivatives include the in situ formation of peroxyacids required to oxidize the oripavine and oripavine derivatives to form intermediates. Improvements to the reduction of the intermediates to form oxycodone and oxycodone derivatives include reducing the use of hydrogen transfer reagents. These improvements allow the generation of oxycodone and oxycodone derivatives without isolating intermediates, which provides a one-pot synthesis method.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015524407-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015524406-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016534999-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S58103490-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017502990-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111205296-A
priorityDate 2007-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005038251-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006093672-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004108090-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005097801-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H1171375-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006084412-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010513260-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004502637-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5668285-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428473212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284603
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457773519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426080502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5324289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71751419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 54.